At the height of the cannabis stocks frenzy there were 17 companies with valuations over $1 billion (see my earlier article here) but most marijuana stocks are now trading at much more attractive sales and projected  EBITDA multiples. Here are the 7 pure marijuana stocks with market caps above $1B.

The list below is ranked in order of highest to lowest with stock prices as September 30th for YTD comparisons and October 11th for the month-to-date prices. GW Pharma and Innovative Industrial Properties (a REIT) only have ancillary exposure to the cannabis market so have been excluded from the list so that the remaining stocks are comparable relative to their performance.

1. Canopy Growth Inc. (TSX:WEED; NYSE:CGC)

• Current Market Cap: $6.52B
• Y-T-D Price Performance: -17.1%
• M-T-D Price Performance: -15.4%

2. Aurora Cannabis Inc. (TSX:ACB; NYSE:ACB)

• Current Market Cap: $3.54B
• Y-T-D Price Performance: -14.2%
• M-T-D Price Performance: -16.5%

3. Cronos Group Inc. (TSX:CRON; Nasdaq:CRON)

• Current Market Cap: $2.63B
• Y-T-D Price Performance: -16.8%
• M-T-D Price Performance: -13.4%

4. Curaleaf Holdings Inc. (CSE:CURA; OTCQX:CURLF)

• Current Market Cap: $2.67B
• 2019 YTD ROI: +35.94%
• Y-T-D Price Performance: +11.0%
• M-T-D Price Performance: +12.4%

5. Tilray Inc. (Nasdaq:TLRY)

• Current Market Cap: $2.02B
• Y-T-D Price Performance: -66.3%
• M-T-D Price Performance: -15.2%

6. Green Thumb Industries Inc. (CSE:GTII; OTCQX: GTBIF)

• Current Market Cap: $1.75B
• Y-T-D Price Performance: -1.3%
• M-T-D Price Performance: +8.9%

7. Aphria Inc. (TSX:APHA; NYSE:APHA)g

• Current Market Cap: $1.08B
• Y-T-D Price Performance: -12.4%
• M-T-D Price Performance: -9.7%

Conclusion

All markets trade in cycles and the cannabis sector is no different so, with the negative CannTrust & vape-related news blowing over, now might well be the time for long-term investors to consider an investment in the above companies while prices are still low.